Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma

por Osoegawa, Atsushi, Kometani, Takuro, Fukuyama, Seiichi, Hirai, Fumihiko, Seto, Takashi, Sugio, Kenji, Ichinose, Yukito
Publicado en Ann Thorac Cardiovasc Surg (2015)

Limb arteriolar vasculitis induced by pembrolizumab plus chemotherapy in a patient with lung cancer

por Takada, Kazuki, Hamatake, Motoharu, Kohashi, Kenichi, Shimamatsu, Shinichiro, Hirai, Fumihiko, Ohmori, Shun, Tagawa, Tetsuzo, Mori, Masaki
Publicado en Int Cancer Conf J (2020)

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

por Esaki, Taito, Seto, Takashi, Ariyama, Hiroshi, Arita, Shuji, Fujimoto, Chinatsu, Tsukasa, Koichiro, Kometani, Takuro, Nosaki, Kaname, Hirai, Fumihiko, Yagawa, Katsuro
Publicado 2011

c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report

por HIRAI, FUMIHIKO, EDAGAWA, MAKOTO, SHIMAMATSU, SHINICHIRO, TOYOZAWA, RYO, TOYOKAWA, GOUJI, NOSAKI, KANAME, YAMAGUCHI, MASAFUMI, SETO, TAKASHI, TWAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Publicado en Mol Clin Oncol (2016)

Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type

por Hirai, Fumihiko, Edagawa, Makoto, Shimamatsu, Shinichiro, Toyozawa, Ryo, Toyokawa, Gouji, Nosaki, Kaname, Yamaguchi, Masafumi, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado en Oncol Lett (2017)

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report

por Yamaguchi, Masafumi, Hirai, Fumihiko, Taguchi, Kenichi, Toyozawa, Ryo, Edagawa, Makoto, Shimamatsu, Shinichiro, Nosaki, Kaname, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado en Surg Case Rep (2017)

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients

por Katsura, Masakazu, Shoji, Fumihiro, Okamoto, Tatsuro, Shimamatsu, Shinichiro, Hirai, Fumihiko, Toyokawa, Gouji, Morodomi, Yosuke, Tagawa, Tetsuzo, Oda, Yoshinao, Maehara, Yoshihiko
Publicado en Cancer Sci (2017)

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer

por HIRAI, FUMIHIKO, SETO, TAKASHI, INAMASU, EIKO, SHIMOKAWA, MOTOTSUGU, TOYOKAWA, GOUJI, YOSHIDA, TSUKIHISA, NOSAKI, KANAME, TAKENAKA, TOMOYOSHI, YAMAGUCHI, MASAFUMI, TAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Publicado en Oncol Lett (2015)

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report

por Takamori, Shinkichi, Yamaguchi, Masafumi, Taguchi, Kenichi, Edagawa, Makoto, Shimamatsu, Shinichiro, Toyozawa, Ryo, Nosaki, Kaname, Hirai, Fumihiko, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado en Surg Case Rep (2017)

A case of different EGFR mutations in surgically resected synchronous triple lung cancer

por Haratake, Naoki, Takenoyama, Mitsuhiro, Edagawa, Makoto, Shimamatsu, Shinichiro, Toyozawa, Ryo, Nosaki, Kaname, Hirai, Fumihiko, Yamaguchi, Masafumi, Taguchi, Kenichi, Seto, Takashi, Ichinose, Yukito
Publicado en J Thorac Dis (2018)

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors

por Nishio, Makoto, Murakami, Haruyasu, Horiike, Atsushi, Takahashi, Toshiaki, Hirai, Fumihiko, Suenaga, Naoko, Tajima, Takeshi, Tokushige, Kota, Ishii, Masami, Boral, Anthony, Robson, Matthew, Seto, Takashi
Publicado en J Thorac Oncol (2015)

Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors

por Shimizu, Toshio, Seto, Takashi, Hirai, Fumihiko, Takenoyama, Mitsuhiro, Nosaki, Kaname, Tsurutani, Junji, Kaneda, Hiroyasu, Iwasa, Tsutomu, Kawakami, Hisato, Noguchi, Kazuo, Shimamoto, Takashi, Nakagawa, Kazuhiko
Publicado en Invest New Drugs (2016)

Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours

por Yonemori, Kan, Tamura, Kenji, Kodaira, Makoto, Fujikawa, Koshi, Sagawa, Tamotsu, Esaki, Taito, Shirakawa, Tsuyoshi, Hirai, Fumihiko, Yokoi, Yuki, Kawata, Toshio, Hatano, Ben, Takahashi, Yasuo
Publicado en Cancer Chemother Pharmacol (2016)

Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report

por Edagawa, Makoto, Haratake, Naoki, Shimamatsu, Shinichiro, Toyozawa, Ryo, Nosaki, Kaname, Hirai, Fumihiko, Yamaguchi, Masafumi, Taguchi, Kenichi, Kaneko, Koichiro, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado en J Thorac Dis (2017)

Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors

por Esaki, Taito, Hirai, Fumihiko, Makiyama, Akitaka, Seto, Takashi, Bando, Hideaki, Naito, Yoichi, Yoh, Kiyotaka, Ishihara, Kae, Kakizume, Tomoyuki, Natsume, Kazuto, Myers, Andrea, Doi, Toshihiko
Publicado en Cancer Sci (2019)

A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase

por Takamori, Shinkichi, Toyokawa, Gouji, Shimokawa, Mototsugu, Kinoshita, Fumihiko, Kozuma, Yuka, Matsubara, Taichi, Haratake, Naoki, Akamine, Takaki, Hirai, Fumihiko, Tagawa, Tetsuzo, Oda, Yoshinao, Maehara, Yoshihiko
Publicado en J Thorac Dis (2019)

Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report

por TOYOKAWA, GOUJI, TAGUCHI, KENICHI, KOJO, MIYAKO, TOYOZAWA, RYO, INAMASU, EIKO, MORODOMI, YOSUKE, SHIRAISHI, YOSHIMASA, TAKENAKA, TOMOYOSHI, HIRAI, FUMIHIKO, YAMAGUCHI, MASAFUMI, SETO, TAKASHI, TAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Publicado 2013

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

por Tamura, Kenji, Hashimoto, Jun, Tanabe, Yuko, Kodaira, Makoto, Yonemori, Kan, Seto, Takashi, Hirai, Fumihiko, Arita, Shuji, Toyokawa, Gouji, Chen, Lan, Yamamoto, Hiroshi, Kawata, Toshio, Lindemann, Justin, Esaki, Taito
Publicado en Cancer Chemother Pharmacol (2016)

Radiological Features of Programmed Cell Death-Ligand 2-positive Lung Adenocarcinoma: A Single-institution Retrospective Study

por TAKADA, KAZUKI, TOYOKAWA, GOUJI, AZUMA, KOICHI, TAKAMORI, SHINKICHI, JOGO, TOMOKO, HIRAI, FUMIHIKO, TAGAWA, TETSUZO, KAWAHARA, AKIHIKO, AKIBA, JUN, OKAMOTO, ISAMU, NAKANISHI, YOICHI, ODA, YOSHINAO, HOSHINO, TOMOAKI, MAEHARA, YOSHIHIKO
Publicado en In Vivo (2018)

Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9

por Hida, Toyoaki, Seto, Takashi, Horinouchi, Hidehito, Maemondo, Makoto, Takeda, Masayuki, Hotta, Katsuyuki, Hirai, Fumihiko, Kim, Young Hak, Matsumoto, Shingo, Ito, Masayuki, Ayukawa, Koichi, Tokushige, Kota, Yonemura, Masataka, Mitsudomi, Testuya, Nishio, Makoto
Publicado en Cancer Sci (2018)